Osimertinib + Savolitinib

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Osimertinib + Savolitinib
Treatment and conditionWhere it standsTrials
Osimertinib + Savolitinib for carcinomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Osimertinib + Savolitinib for neoplasm metastasisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1